1. Acute effects of nonexcitatory electrical stimulation during systole in isolated cardiac myocytes and perfused heart. Issue 8 (5th August 2014) Authors: Blinova, Ksenia; Stohlman, Jayna; Krauthamer, Victor; Knapton, Alan; Bloomquist, Erik; Gray, Richard A. Journal: Physiological reports Issue: Volume 2:Issue 8(2014:Aug.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis. Issue 2 (February 2020) Authors: Gao, Jennifer J; Cheng, Joyce; Bloomquist, Erik; Sanchez, Jacquelyn; Wedam, Suparna B; Singh, Harpreet; Amiri-Kordestani, Laleh; Ibrahim, Amna; Sridhara, Rajeshwari; Goldberg, Kirsten B; Theoret, Marc R; Kluetz, Paul G; Blumenthal, Gideon M; Pazdur, Richard; Beaver, Julia A; Prowell, Tatiana M Journal: Lancet oncology Issue: Volume 21:Issue 2(2020) Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast Cancer. Issue 11 (10th April 2022) Authors: Royce, Melanie; Osgood, Christy; Mulkey, Flora; Bloomquist, Erik; Pierce, William F.; Roy, Arpita; Kalavar, Shyam; Ghosh, Soma; Philip, Reena; Rizvi, Fatima; Mixter, Bronwyn D.; Tang, Shenghui; Pazdur, Richard; Beaver, Julia A.; Amiri-Kordestani, Laleh Journal: Journal of clinical oncology Issue: Volume 40:Issue 11(2022) Page Start: 1155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer. (20th October 2020) Authors: Arora, Shaily; Balasubramaniam, Sanjeeve; Zhang, Hui; Berman, Tara; Narayan, Preeti; Suzman, Daniel; Bloomquist, Erik; Tang, Shenghui; Gong, Yutao; Sridhara, Rajeshwari; Turcu, Francisca Reyes; Chatterjee, Deb; Saritas‐Yildirim, Banu; Ghosh, Soma; Philip, Reena; Pathak, Anand; Gao, Jennifer J.; A... Journal: Oncologist Issue: Volume 26:Number 1(2021) Page Start: e164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA‐Mutated Metastatic Castrate‐Resistant Prostate Cancer. (17th November 2020) Authors: Anscher, Mitchell S.; Chang, Elaine; Gao, Xin; Gong, Yutao; Weinstock, Chana; Bloomquist, Erik; Adeniyi, Oluseyi; Charlab, Rosane; Zimmerman, Sarah; Serlemitsos‐Day, Maritsa; Ning, Yang Min; Mayrosh, Ruth; Fuller, Barbara; Trentacosti, Ann Marie; Gallagher, Pamela; Bijwaard, Karen; Philip, Reena;... Journal: Oncologist Issue: Volume 26:Number 2(2021) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Overall survival in patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer treated with a cyclin-dependent kinase 4/6 inhibitor plus fulvestrant: a US Food and Drug Administration pooled analysis. Issue 11 (November 2021) Authors: Gao, Jennifer J; Cheng, Joyce; Prowell, Tatiana M; Bloomquist, Erik; Tang, Shenghui; Wedam, Suparna B; Royce, Melanie; Krol, Danielle; Osgood, Christy; Ison, Gwynn; Sridhara, Rajeshwari; Pazdur, Richard; Beaver, Julia A; Amiri-Kordestani, Laleh Journal: Lancet oncology Issue: Volume 22:Issue 11(2021) Page Start: 1573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience. Issue 8 (2nd April 2021) Authors: Lee, Eudocia Q; Selig, Wendy; Meehan, Clair; Bacha, Jeffrey; Barone, Amy; Bloomquist, Erik; Chang, Susan M; de Groot, John F; Galanis, Evanthia; Hassan, Islam; Kalidas, Chitkala; Khasraw, Mustafa; Kvedar, Joseph C; Lassman, Andrew B; Puduvalli, Vinay; Sahebjam, Solmaz; Schwamm, Lee H; Tamir, Shar... Journal: Neuro-oncology Issue: Volume 23:Issue 8(2021) Page Start: 1252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. U.S. Food and Drug Administration Approval Summary: Ramucirumab for the Treatment of Metastatic Non-Small Cell Lung Cancer Following Disease Progression On or After Platinum-Based Chemotherapy. (7th October 2015) Authors: Larkins, Erin; Scepura, Barbara; Blumenthal, Gideon M.; Bloomquist, Erik; Tang, Shenghui; Biable, Missiratch; Kluetz, Paul; Keegan, Patricia; Pazdur, Richard Journal: Oncologist Issue: Volume 20:Number 11(2015) Page Start: 1320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. U.S. Food and Drug Administration Approval Summary: Ramucirumab for the Treatment of Metastatic Non‐Small Cell Lung Cancer Following Disease Progression On or After Platinum‐Based Chemotherapy. (7th October 2015) Authors: Larkins, Erin; Scepura, Barbara; Blumenthal, Gideon M.; Bloomquist, Erik; Tang, Shenghui; Biable, Missiratch; Kluetz, Paul; Keegan, Patricia; Pazdur, Richard Journal: Oncologist Issue: Volume 20:Number 11(2015) Page Start: 1320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. U.S. Food and Drug Administration Benefit‐Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained Molecular Remission. (24th April 2019) Authors: Pulte, E. Dianne; Wroblewski, Tanya; Bloomquist, Erik; Tang, Shenghui; Farrell, Ann; Deisseroth, Albert; McKee, Amy E.; Pazdur, Richard Journal: Oncologist Issue: Volume 24:Number 5(2019) Page Start: e188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗